formosanin C
|
|
|
- CAS-Nr.
- 50773-42-7
- Englisch Name:
- formosanin C
- Synonyma:
- Asperin;Paris II;formosanin C;Parrisaponin;Parissaponin Pb;Formosanin C-RM;Paris saponin II;Aesculus extract;Polyphyllin B, ≥98%;Polyphyllin B (ForMosanin C)
- CBNumber:
- CB91349000
- Summenformel:
- C51H82O20
- Molgewicht:
- 1015.2
- MOL-Datei:
- 50773-42-7.mol
|
formosanin C Eigenschaften
- Schmelzpunkt:
- 222～231℃
- Dichte
- 1.43±0.1 g/cm3(Predicted)
- storage temp.
- -20°C, protect from light
- L?slichkeit
- Soluble in pyridine;
- pka
- 12?+-.0.70(Predicted)
- Aggregatzustand
- powder
- Farbe
- White
- Wasserl?slichkeit
- sparingly soluble in water
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
| Sicherheit |
| P264 |
Nach Gebrauch gründlich waschen. |
| P264 |
Nach Gebrauch gründlich waschen. |
| P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
| P301+P312 |
BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
| P330 |
Mund ausspülen. |
| P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
formosanin C Chemische Eigenschaften,Einsatz,Produktion Methoden
formosanin C Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
formosanin C Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 100)Lieferanten
50773-42-7()Verwandte Suche:
Nystatin
3-((2,6-Didesoxy-beta-D-ribo-hexo-pyranosyl)oxy)-5,14-dihydroxy-19-oxo-card-20(22)-enolid,(3 beta, 5 beta)-
Bufa-20,22-dienolid, 3,5,14-Trihydroxy-19-oxo-, (3β,5β)-
Aconitan-3,8,13,14,15-pentol, 1,6,16-Trimethoxy-4-(methoxymethyl)-20-methyl-, 8-Acetat-14-benzoat, (1α,3α,6α,14α,15α,16β)-
- (3beta,25R)-Spirost-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-[O-6-deoxy-alpha-L-mannopyranosyl-(1-4)-6-deoxy-alpha-L-mannopyranosyl-(1-4)]-beta-D-glucopyranoside
- Paris II
- Paris saponin II
- Parissaponin Pb
- Parrisaponin
- formosanin C
- Polyphyllin B (ForMosanin C)
- Asperin
- Polyphyllin B, ≥98%
- b-D-Glucopyranoside, (3b,25R)-spirost-5-en-3-ylO-6-deoxy-a-L-mannopyranosyl-(12)-O-[O-6-deoxy-a-L-mannopyranosyl-(14)-6-deoxy-a-L-mannopyranosyl-(14)]-
- β-D-Glucopyranoside, (3β,25R)-spirost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[O-6-deoxy-α-L-mannopyranosyl-(1→4)-6-deoxy-α-L-mannopyranosyl-(1→4)]-
- Aesculus extract
- Polyphyllin II/Paridis saponin II
- Formosanin C,inhibit,Inhibitor,Apoptosis
- (2S,3R,4R,5R,6S)-2-(((2S,3R,4S,5R,6S)-4,5-dihydroxy-6-(((2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-(((2'R,4S,5'R,6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-yl)oxy)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4R,5R,6S)-2-(((2S,3R,4S,5R,6S)-4,5-Dihydroxy-6-(((2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-(((2'R,4S,5'R,6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-yl)oxy)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
- Formosanin C-RM
- (2S,3R,4R,5R,6S)-2-(((2S,3R,4S,5R,6S)-4,5-Dihydroxy-6-(((2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-(((4S,5'R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-yl)oxy)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-2-methyltetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol
- 50773-42-7
